Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the Assent-3 randomised trial in acute myocardial infarction.

Details

Serval ID
serval:BIB_21288
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the Assent-3 randomised trial in acute myocardial infarction.
Journal
The Lancet
Author(s)
The Assessment of the Safety
Publication state
Published
Issued date
2001
Volume
358
Pages
605-613
Notes
Efficacy of a New Thrombolytic Regimen (Assent)-3 Investigators.
Create date
19/11/2007 12:17
Last modification date
20/08/2019 12:57
Usage data